Welcome to a new episode of the Biedex Markets Psychedelics Podcast where we’re joined by Robert Barrow, CEO of Mind…
Former Dragons’ Den investor and AI expert Piers Linney has partnered with leading growth consultancy firm Champions (UK) plc. …
Wednesday, Acelyrin Inc SLRN released proof-of-concept data from an ongoing Phase 1/2 trial of lonigutamab in thyroid eye disease (TED). Lonigutamab is a…
Among brain tumors, high-grade gliomas are the most frequently diagnosed and fatal. Most of the patients with high-grade glioma will…
Monday, Acelyrin Inc SLRN announced that its global Phase 2b/3 clinical trial of izokibep in psoriatic arthritis (PsA) met the primary endpoint…
Morgan Stanley initiates Arcellx Inc ACLX, noting a differentiated CAR-T platform for blood cancer backed by an established CAR-T partner. ddBCMA (aka anito-cel)…
Gain Therapeutics Inc GANX announces the presentation of a poster at the International Conference on Alzheimer’s and Parkinson’s Diseases and related…
Source: Blackboard / Shutterstock Discovering technological innovations and finding industry leaders can help investors outperform the stock market. This strategy…
Monday, ARS Pharmaceuticals Inc SPRY released efficacy results in its phase 2 inpatient chronic spontaneous urticaria study with neffy (epinephrine nasal spray),…
TokenFi price has formed a double bottom setup, forecasting a 28% move to the upside. Investors can expect a minimum…